The Boston Globe - Dartmouth researchers Lisa Schwartz and Steven Woloshin are looking into two new weight loss drugs—Belviq and Qysmia—which they say "have been associated with serious harms." Advising the public, they say, "until there is more convincing evidence about the cardiovascular safety of these drugs, physicians and patients should approach them cautiously." Schwartz and Woloshin are both professors of medicine and of community and family medicine, as well as co-directors of the Medicine and the Media program. Read more...